DE69813903D1 - Antikrebs-platin-(vi)-komplexe zur oralen verabreichung - Google Patents

Antikrebs-platin-(vi)-komplexe zur oralen verabreichung

Info

Publication number
DE69813903D1
DE69813903D1 DE69813903T DE69813903T DE69813903D1 DE 69813903 D1 DE69813903 D1 DE 69813903D1 DE 69813903 T DE69813903 T DE 69813903T DE 69813903 T DE69813903 T DE 69813903T DE 69813903 D1 DE69813903 D1 DE 69813903D1
Authority
DE
Germany
Prior art keywords
complexes
oral administration
platinum
cancer
cancer platinum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69813903T
Other languages
English (en)
Other versions
DE69813903T2 (de
Inventor
Soo Sohn
Sil Lee
Young-A Lee
Mook Kim
Ock Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Institute of Science and Technology KIST
Original Assignee
Korea Institute of Science and Technology KIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Institute of Science and Technology KIST filed Critical Korea Institute of Science and Technology KIST
Publication of DE69813903D1 publication Critical patent/DE69813903D1/de
Application granted granted Critical
Publication of DE69813903T2 publication Critical patent/DE69813903T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/122—Propionic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/09—Diamines
    • C07C211/10—Diaminoethanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/09—Diamines
    • C07C211/11—Diaminopropanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • C07C211/18—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing at least two amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/36—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing at least two amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/124—Acids containing four carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69813903T 1997-12-30 1998-12-23 Antikrebs-platin-(vi)-komplexe zur oralen verabreichung Expired - Fee Related DE69813903T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019970079743A KR100246722B1 (ko) 1997-12-30 1997-12-30 경구용 백금 착화합물 항암제 및 그 제조방법
PCT/KR1998/000456 WO1999033782A1 (en) 1997-12-30 1998-12-23 Anticancer platinum (iv) complexes for oral administration

Publications (2)

Publication Number Publication Date
DE69813903D1 true DE69813903D1 (de) 2003-05-28
DE69813903T2 DE69813903T2 (de) 2003-12-18

Family

ID=19530197

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69813903T Expired - Fee Related DE69813903T2 (de) 1997-12-30 1998-12-23 Antikrebs-platin-(vi)-komplexe zur oralen verabreichung

Country Status (9)

Country Link
US (1) US5998648A (de)
EP (1) EP1051387B1 (de)
JP (1) JP3648452B2 (de)
KR (2) KR100246722B1 (de)
AT (1) ATE238269T1 (de)
AU (1) AU1693899A (de)
DE (1) DE69813903T2 (de)
ES (1) ES2196634T3 (de)
WO (1) WO1999033782A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229934B1 (de) 1999-10-01 2014-03-05 Immunogen, Inc. Zusammensetzungen und verfahren zur behandlung von krebs mittels immunkonjugaten und chemotherapeutischen agenzien
RU2178702C1 (ru) * 2001-02-21 2002-01-27 Общество с ограниченной ответственностью "Нобель" Антираковое средство
JP2007502777A (ja) * 2003-08-13 2007-02-15 ユニバーシティー オブ サウス フロリダ 腫瘍の処置のための白金錯体
US20050288365A1 (en) * 2004-01-06 2005-12-29 Heidi Kay Platinum complexes and methods for inhibiting tumor cell proliferation
CZ2004964A3 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
WO2007008247A2 (en) * 2004-11-10 2007-01-18 University Of South Florida Platinum complexes for targeted drug delivery
KR100698609B1 (ko) * 2005-05-06 2007-03-22 서울시립대학교 산학협력단 심지 급수형 화분
WO2007006019A1 (en) * 2005-07-06 2007-01-11 University Of South Florida Materials and methods for screening, diagnosis and prognosis of conditions associated with stat protein expression
ATE484286T1 (de) * 2005-09-12 2010-10-15 N Yogesh Bendale Neues bioplatin, herstellungsverfahren, verfahren zur verabreichung einer antitumoralen behandlung
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
EP2208731B1 (de) * 2009-06-26 2012-08-15 Umicore AG & Co. KG Verfahren zur Herstellung von 1,2-Diamino-Cyclohexan-Platin(II)-Komplexen
KR20240025177A (ko) 2022-08-18 2024-02-27 정민우 왜곡현상을 방지하는 광학용 오목렌즈 및 광학용 오목렌즈 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937358A (en) * 1987-06-23 1990-06-26 American Cyanamid Company Synthesis of cisplatin analogs
US4996337A (en) * 1987-06-23 1991-02-26 American Cyanamid Company Synthesis of cisplatin analogs
US5072011A (en) * 1988-02-02 1991-12-10 Johnson Matthey, Inc. Pt(IV) complexes
ATE113054T1 (de) * 1988-02-02 1994-11-15 Johnson Matthey Inc Pt(iv) komplexe.
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
JPH07138274A (ja) * 1993-11-12 1995-05-30 Tanaka Kikinzoku Kogyo Kk Ｚ軸上に脂溶性基を有する抗腫瘍性シクロヘキサンジアミン誘導体白金（ｉｖ）錯体
EP0646589A3 (de) * 1993-10-04 1995-06-28 Tanaka Precious Metal Ind Anti-tumor Platin (IV) Komplexe.
JPH07101970A (ja) * 1993-10-04 1995-04-18 Tanaka Kikinzoku Kogyo Kk 抗腫瘍性シクロヘキサンジアミン誘導体の脂溶性新規白金（ｉｖ）錯体
EP0909288B1 (de) * 1996-07-02 2007-06-27 Ciba SC Holding AG Verfahren zur vernetzung einen polymerisierbaren zusammensetzung
JPH10251285A (ja) * 1997-03-14 1998-09-22 Ss Pharmaceut Co Ltd 白金（ｉｖ）錯体及びこれを含有する医薬

Also Published As

Publication number Publication date
KR20000064233A (ko) 2000-11-06
ATE238269T1 (de) 2003-05-15
EP1051387A1 (de) 2000-11-15
EP1051387B1 (de) 2003-04-23
KR100246722B1 (ko) 2000-04-01
WO1999033782A1 (en) 1999-07-08
JP3648452B2 (ja) 2005-05-18
KR19990059535A (ko) 1999-07-26
JP2001527059A (ja) 2001-12-25
AU1693899A (en) 1999-07-19
KR100377328B1 (ko) 2003-03-26
ES2196634T3 (es) 2003-12-16
US5998648A (en) 1999-12-07
DE69813903T2 (de) 2003-12-18

Similar Documents

Publication Publication Date Title
DE69813903T2 (de) Antikrebs-platin-(vi)-komplexe zur oralen verabreichung
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
DE69520880T2 (de) 9-deoxotaxan verbindungen
HRP20041042A2 (en) Novel substituted sulfamate anticonvulsant derivatives
TR200200416T2 (tr) İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.
HUP0004226A2 (hu) Új D-vitamin-analógok, ezeket tartalmazó gyógyászati készítmény és eljárás előállításukra
ATE196138T1 (de) Halichondrine und verwandte verbindungen
JPS6438009A (en) Beautifying cosmetic
PL289487A1 (en) Method of producing new aminophenol derivatives
NO20050640L (no) Rutenium anticancer komplekser
FI88717C (fi) Foerfarande foer framstaellning av som laekemedel anvaendbara cyklopenta/d/pyrimidinderivat
ATE176478T1 (de) Trinukleare kationische platinkomplexe mit antitumor wirkung sowie diese enthaltende pharmazeutische zusammensetzungen
HUP9801363A2 (hu) Biciklusos izotiokarbamidszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
GEP20012517B (en) Taxoids, Method for Their Preparation and Pharmaceutical Compositions Containing Same
FI870460A (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-substituerade oktahydroindolizinderivat och vid foerfarandet anvaendbara mellanprodukter.
HUP0300198A2 (hu) Tiokolkicin és bakkatin kondenzációs származékai és ilyen vegyületeket tartalmazó, tumor elleni hatású gyógyászati készítmények
HUP9903514A2 (hu) Cikloalkilén-lánccal rendelkező új ciklusos vegyületek, eljárás azok előállítására és az azokat tartalmazó gyógyszerkészítmények
HUP0002457A1 (hu) 4-Halogénezett szteroidszármazékok, eljárás előállításukra, ezek intermedierjei, és ezeket tartalmazó gyógyszerkészítmények
ATE99666T1 (de) Platinkomplexe und antitumormittel, die diese als wirkstoffe enthalten.
ATE64740T1 (de) Platin enthaltender cytostatischer wirkstoff.
KR930000529A (ko) 백금(ii)착체 및 종양치료제
EA200100940A1 (ru) Водорастворимые трансплатиновые комплексы, обладающие противораковым действием, способ их получения и способ лечения
KR920701221A (ko) 신규한 백금 착체 및 이를 유효성분으로 하는 항종양제
ATE299492T1 (de) Cyclophilin-bindende ligande
TH55706B (th) ยาคลายกล้ามเนื้อที่ออกฤทธิ์ที่รอยต่อระหว่างประสาทและกล้ามเนื้อพวกโนโน-เอซิลออกซิแอรัลคิล

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee